My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Hypometabolism as a therapeutic target in Alzheimer's disease.

    Costantini LC, Barr LJ, Vogel JL, Henderson ST.

    BMC Neurosci. 2008 Dec 3;9 Suppl 2:S16. Review.PMID: 19090989 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.

    Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S.

    Neurobiol Aging. 2004 Mar;25(3):311-4.PMID: 15123336 [PubMed - indexed for MEDLINE]Related articles

    3.

    A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.

    Heininger K.

    Rev Neurosci. 2000;11 Spec No:213-328. Review.PMID: 11065271 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

    Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

    Arch Neurol. 1998 Mar;55(3):326-35.PMID: 9520006 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.

    Am J Psychiatry. 2002 May;159(5):738-45.PMID: 11986126 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

    Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

    Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.PMID: 10669911 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.

    DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI.

    J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):158-67.PMID: 8708645 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

    Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L, et al.

    JAMA. 1995 Mar 22-29;273(12):942-7.PMID: 7884953 [PubMed - indexed for MEDLINE]Related articles

    9.

    Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

    Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D.

    N Engl J Med. 1996 Mar 21;334(12):752-8.PMID: 8592548 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

    Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

    Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.PMID: 17962045 [PubMed - indexed for MEDLINE]Related articles

    11.

    Ketone bodies as a therapeutic for Alzheimer's disease.

    Henderson ST.

    Neurotherapeutics. 2008 Jul;5(3):470-80. Review.PMID: 18625458 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reduced neuronal activity and reactivation in Alzheimer's disease.

    Swaab DF, Lucassen PJ, Salehi A, Scherder EJ, van Someren EJ, Verwer RW.

    Prog Brain Res. 1998;117:343-77. Review.PMID: 9932420 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

    Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

    Neurology. 2005 Mar 8;64(5):834-41.PMID: 15753419 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease]

    Zhang XQ, Min BQ, Ma YC, Yang PJ, Li DP.

    Zhonghua Yi Xue Za Zhi. 2003 Jan 25;83(2):100-2. Chinese. PMID: 12812674 [PubMed - indexed for MEDLINE]Related articles

    15.

    Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.

    Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C.

    Brain. 1999 Aug;122 ( Pt 8):1519-31.PMID: 10430835 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.

    Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W.

    Arch Neurol. 2008 May;65(5):650-5.PMID: 18474742 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.

    Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, Nordberg A.

    Arch Neurol. 1997 Mar;54(3):273-7.PMID: 9074396 [PubMed - indexed for MEDLINE]Related articles

    18.

    Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.

    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.

    Am J Psychiatry. 1996 Oct;153(10):1261-8.PMID: 8831432 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

    Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, Itoh M, Shin RW, Trojanowski JQ, Sasaki H.

    Exp Neurol. 2000 Apr;162(2):247-56.PMID: 10739631 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.

    Bokde AL, Pietrini P, Ibáñez V, Furey ML, Alexander GE, Graff-Radford NR, Rapoport SI, Schapiro MB, Horwitz B.

    Arch Neurol. 2001 Mar;58(3):480-6.PMID: 11255453 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity